EMA and EMACO Chemotherapy in High Risk Gestational Trophoblast Disease, which Better?
Abstract Objective: Determine the best effectiveness and efficacy between EMA and EMACO for patients with high-risk GTN. Results: GTN patients who received EMA showed remissions as high as 74.4% - 96.6% of cases. The side effects of anemia in EMA were less toxic than EMACO, but it wasn't the ca...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | |
| Опубликовано: |
Indonesian Society of Obstetrics and Gynecology,
2022-07-01T00:00:00Z.
|
| Предметы: | |
| Online-ссылка: | Connect to this object online. |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Копировать 1 | Доступно |